Nice to have your opinion ricm. Do you think with the change of board there is any hope for Oraline reaching the market again if they are able to use their Chinese partner? Oral fluid testing doesn't seem to have progressed a lot over the years, so perhaps Oraline hasn't been totally left behind.
Or do you think SBN as a biotech should just pursue other avenues, such as the Parvulus transaction?
what are your thoughts on this part of their AGM presentation?
cheers
- Forums
- ASX - By Stock
- small cap bio, massive potential only $4m m/c
Nice to have your opinion ricm. Do you think with the change of...
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online